medigraphic.com

2002, Number 3

<< Back Next >>

Cir Cir 2002; 70 (3)

Women´s health investigation in the twenty-first century

Chavarría-Olarte ME, Palomo-Piñón S, Danel I, Granados-Martínez J

Language: Spanish
References: 60
Page: 194-199
PDF size: 50.88 Kb.


ABSTRACT




REFERENCES

  1. Goldman MB, Hatch MC, editors. Women and health. New York: Academic Press; 2000.

  2. Day JC. Population projections of the United States by age, sex, race, and Hispanic origin: 1995-2050. Washington D.C., USA: Bureau of the Census. Current Population Reports; 1996.pp.25-1130.

  3. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000;49:147-152.

  4. Giijsbers van Wijk CMT, Kolk AM van den Bosch WJHM, wan den Hoogen HJM. Male and female morbidity in general practice the nature of sex differences. Soc Sci Med 1992;35:665-678.

  5. Kenney JW, Bhattacharjee A. Interactive model of women’s stressors, personality traits and health problems. J Adv Nurs 2000; 32:249-258.

  6. Barnett RC, Marshal NL. The relationship between women’s work and family roles, and their subjective well-being and psychological distress. In: Frankenheuser M, Lundberg U, Chesney M, editors. Woman, Work, and Health: Streess and Opportunities. New York: Plenum Press; 1991.

  7. Hibbard JH, Pope CR. The quality of social roles as predictors of morbidity and mortality. Soc Sci Med 1993;36:217-225.

  8. Gesensway D. Reasons for sex-specific and gender-specific studies of health topics. Ann Intern Med 2001;135:935-938.

  9. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325:221-225.

  10. Giles WH, Anda RF, Casper ML, Escobedo LG, Taylor HA. Race and sex differences in rates of invasive cardiac procedures in US hospitals: data from the National Hospital Discharge Survey. Arch Intern Med 1995;155:318-324.

  11. Mendelssohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.

  12. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial: the Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.

  13. Hanania NA, Chapman KR, Sturtridge WC, et al. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-579.

  14. Ip M, Lam K, Yam L, et al. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhalated steroids. Chest 1994;105:1722-1727.

  15. Chalk R, King PA. Violence in families: assessing prevention and treatment programs. In: Chalk R, King PA, editors. Health care interventions. Washington D.C., USA: National Academy Press; 1998..223-224.

  16. Williams JBW, Spitzer RL, Linzer M, Kroenke K, Hahn SR, et al. Gender differences in depression in primary care. Am J Obstet Gynecol 1995;173:654-659.

  17. Developmental biology. Understanding normal and abdominal development. NICHD Report 2001. http://www.nichd.nih.gov/publications/

  18. Genetics and fetal antecedents of disease susceptibility. NICHD Report 2001. http://www.nichd.nih.gov/publications/

  19. America’s children: key national Indicators of well-being. NICHD Report 2001. http://childstats.gov/

  20. Zametkin AJ, Alter MR, Yemini T. Suicide in teenagers: assessment, management, and prevention. JAMA 2001;286:3120-3125.

  21. Endocrinology, nutrition, and growth branch: Report to the NACHHD Council. September 2000. http://www.nichd.nih.gov/publications/

  22. Division of Epidemiology, Statistics, and Prevention Research: Report to the NACHHD Council. June 2001. http://www.nichd.nih.gov/publications/

  23. Contraception and reproductive health branch: Report to the NACHHD Council. September 1999. http://www.nichd.nih.gov/publications/

  24. Pregnancy and perinatology branch: Report to the NACHHD Council. January 2000. http://www.nichd.nih.gov/publications/

  25. Ness RB, Kuller LH. Health and disease among women: biological and environmental influences. Oxford, UK: Oxford University Press; 2000.

  26. Sword W. A socio-ecological approach to understanding barriers to prenatal care for women of low income. J Adv Nurs. 1999;29:1170-1177.

  27. Bauer GR, Welles SL. Beyond assumptions of negligible risk: sexually transmitted diseases and women who have sex with women. Am J Public Health 2001;91:1282-1286.

  28. Kiecolt-Glaser JK, Glaser R. Psychological influences on immunity: implications for AIDS. Am Psychol 1988;43:892-898.

  29. Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 1998;60:150-155.

  30. Linzer M, Spitzer R, Kroenke K, et al. Gender, quality of life and mental disorders in primary care: results from the PRIME-MD 1000 study. Am J Med 1996;101:526-533.

  31. McCauley J, Kern DE, Kolodner K, et al. The “battering syndrome”: prevalence and clinical characteristics of domestic violence in primary care internal medicine practices. Ann Intern Med 1995;123:737-746.

  32. Drossman DA, Talley MJ, Leserman J, et al. Sexual and physical abuse in gastrointestinal illness: review and recommendations. Ann Int Med 1995;123:782-794.

  33. Feuer EJ, Wun LM, Boring CC. Probability of developing cancer. In: Miller BA, Ries LAG, Hankey BF, Kosary CL, SEER cancer statistics review: 1973-89. Vol. 30. Edwards BK, editors. Bathesda, MD, USA: National Cancer Institute; 1992.pp.1-13. NIH publications 92-2789.

  34. Fox SA, Roetzheim RG, Kington RS. Barriers to cancer prevention in the older person. In: Balducci L, Lyman GH, Ershler WB, editors. Comprehensive geriatric oncology. Philadelphia, PA, USA: JB Lippincott; 1997.pp.351-361.

  35. Roetzheim R, Fox SA, Leake B, Houn F. The National Cancer Institute Breast Cancer Screening Consortium. The influence of risk factors on breast carcinoma screening of Medicare-insured older women. Cancer 1996;78:2526-2534.

  36. Weiderpass E, Persson I, Melhus H, et al. Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 2000;21:623-627.

  37. Schuur ER, Weigel RJ. Monoallelic amplification of estrogen receptor-alpha expression in breast cancer. Cancer Res 2000;60:2598-2601.

  38. Georgiou I, Syrrou M, Bouba I, et al. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 1999;n 72:164-166.

  39. Ji Y, Urakami K, Wada-isoe K, et al. Estrogen receptor gene polymorphisms in patients with Alzheimer’s disease, vascular dementia, and alcohol-associated dementia. Dement Geriatr Cong Disord 2000;11:119-122.

  40. Isoe-Wada K, Maeda M, Yong J, et al. Positive association between an estrogen receptor gene polymorphism and Parkinson’s disease with dementia. Eur J Neurol 1999;6:431-435.

  41. Hunt L. Women’s health: mental health needs. Nurs Manage (London) 1998;5:18-20.

  42. Shah N, Evans WS, Bowers CY, Veldhuis JD. Oral stradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women. J Clin Endocrinol Metab 2000;85:2649-2659.

  43. Gijsbers van Wijk CMT, van Vliet KP, Kolk AM, et al. Symptom sensitivity and sex differences in physical morbidity: a review of health surveys in the US and the Netherlands. Women Health 1991;17:91-124.

  44. Mosca L, Collins P, Herrington D, Mendelsohn ME, Pasternak RC, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:499-503.

  45. Butler RN. Sounding board on behalf of older women: another reason to protect Medicare and Medicaid. N Engl J Med 1996;334:794-796.

  46. Mosca L, Jones WK, King KB, et al. Awareness, perception and knowledge of heart disease risk and prevention among women in the United States: American Heart Association Women’s Heart Disease and Stroke Campaign Task Force. Arch Fam Med 2000;9:506-515.

  47. Giguere Y, Rousseau F. The genetics of osteoporosis: complexities and difficulties. Clin Genet 2000;57:161-169.

  48. Callahan D, ter Meulen RHJ, Topinkova E. A world growing old: the coming health care challenges. Washington, D.C., USA: Georgetown University Press; 1995.

  49. Ebrahim S, Kalach A. Epidemiology in old age. London: BMJ Publishing Group; 1996.

  50. Butler RM. Population againg and health. BMJ 1997;315:1082-1084.

  51. Merzel C. Gender differences in health care access indicators in an urban, low-income community. Am J Public Health 2000;90: 909-916.

  52. Subramanian G, Adams MD, Venter JC, Broder S. Implications of the human genome for understanding human biology and medicine. JAMA 2001;286:2296-2307.

  53. Collins FS, McKusick VA. Implications of the human genome project for medical science. JAMA 2001;285:540-544.

  54. Schimpf MO, Domino SE. Implications of the human genome project for obstetrics and gynecology. Obstet Gynecol Surv 2001;56:437-443.

  55. McKusick VA. The anatomy of the human genome: a neo-Vesalian basis for medicine in the 21st century. JAMA 2001;286:2289-2295.

  56. Van Dyke DC, Ellingrod VL, Berg MJ, et al. Pharmacogenetic screening for susceptibility to fetal malformations in women. Ann Pharmacother 2000;34:639-645.

  57. Thompson L. Correcting the code: inventing the genetic cure for the human body. New York: Simon & Schuster; 1994.

  58. Murphy TF, Lappe MA. Justice and the human genome project. Berkeley CA, USA: University of California Press; 1994.

  59. Jeffords JM, Daschle T. Political issues in the genome era. Science 2001;291:1249-1251.

  60. Vastag B. Experts wrestle with social, ethical implications of human genome research. JAMA 2001;285:721-722.




2020     |     www.medigraphic.com